On August 1, the 7th China Pharmaceutical Industry Expo (CMC-CHINA 2025) opened in Suzhou with the theme “Breakthrough, Symbiosis and Globalization” and a focus on “Finding Direction and Driving Growth”. During this prominent industry event, Biokin Pharmaceutical was honored with inclusion on both the “2025 Top 101 Chinese Pharmaceutical Industries" and the "2025 Top 101 Chinese Innovative Drugs" lists.
Jointly selected by the Expo’s organizing committee and the industry authority PharmaBIG, the ranking has identified the most innovative and promising pharmaceutical companies through a rigorous and comprehensive evaluation from the perspective of market capitalization, financial performance, R&D pipeline, commercialization, R&D investment, incubation, and business development (BD). The list offers an objective view of the comprehensive landscape among China’s leading innovative drug companies and serves as an authoritative representation of the industry’s top echelon.
